Publications

CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis

 101
CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis

Tags:

Previous Article

The maternal microbiome during pregnancy impacts offspring’s stem cells in mice

Next Article

CAR-T cells for multiple sclerosis

Related Posts

Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer’s disease model

Microglia depletion reduces human neuronal APOE4-relate...

 126

Multi-modal dissection of cell-type specific TDP-43 pathology in the motor cortex

Multi-modal dissection of cell-type specific TDP-43 pat...

 26

Mutations in mitochondrial ferredoxin FDX2 suppress frataxin deficiency

Mutations in mitochondrial ferredoxin FDX2 suppress fra...

 28